Trademark Overview
On Friday, March 15, 2024, a trademark application was filed for BREAKTHROUGH T1D with the United States Patent and Trademark Office. The USPTO has given the BREAKTHROUGH T1D trademark a serial number of 98451675. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Sunday, March 17, 2024. This trademark is owned by JDRF International. The BREAKTHROUGH T1D trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Charitable fundraising; online charitable fundraising; charitable fundraising services by means of organizing and conducting special events; charitable fundraising services by means of running and walking events; charitable fundraising services for promoting research and education relating to type 1 diabetes; charitable foundation services, namely, providing fundraising activities and investment management services to support type 1 diabetes research
Association services, namely, promoting the public interest and awareness of curing, treating, and preventing type 1 diabetes; promoting public awareness of type 1 diabetes, type 1 diabetes research, and treatments, preventions and cures for type 1 diabetes, by means of public advocacy
Providing information in the field of prevention, screening, diagnosis and treatment of type 1 diabetes; providing information in the field of prevention, screening, diagnosis and treatment of type 1 diabetes via a website; providing health information; providing health information in the field of type 1 diabetes
Providing information about medical research; providing information about medical research in the field of type 1 diabetes; Providing information about medical and scientific research via a website; Providing medical and scientific research information in the field of clinical trials; Providing an online database in the field of medical and scientific research as it relates to type 1 diabetes